Article
Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
Future oncology (London, England) - 1 Sept 2015
Maleszewska Marta, Kaminska Bozena
Abstract excerpt
The epigenetic landscape is deregulated in cancer due to aberrant activation or inactivation of enzymes maintaining and modifying the epigenome. Histone modifications and global aberrations at the histone level may result in distorted patterns of gene expression, and malfunction of proteins that regulate chromatin modification and remodeling. Recent whole genome studies demonstrated that histones and chaperone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
